Dietary supplementation with vitamin E ameliorates cardiac failure in type I diabetic cardiomyopathy by suppressing myocardial generation of 8-iso-prostaglandin F2alpha and oxidized glutathione
about
Enhanced skeletal muscle expression of extracellular superoxide dismutase mitigates streptozotocin-induced diabetic cardiomyopathy by reducing oxidative stress and aberrant cell signaling.Emerging role for antioxidant therapy in protection against diabetic cardiac complications: experimental and clinical evidence for utilization of classic and new antioxidantsGlycoxidative stress and cardiovascular complications in experimentally-induced diabetes: effects of antioxidant treatmentReactive oxygen species in cardiovascular disease.Type 1 diabetes mellitus abrogates compensatory augmentation of myocardial neuregulin-1β/ErbB in response to myocardial infarction resulting in worsening heart failure.Augmented cardiac formation of oxidatively-induced carbonylated proteins accompanies the increased functional severity of post-myocardial infarction heart failure in the setting of type 1 diabetes mellitus.Effects of cyclooxygenase-2 gene inactivation on cardiac autonomic and left ventricular function in experimental diabetesEvaluation of Cardiac Functions in Children and Adolescents with Type 1 DiabetesOxidative stress in heart failure: what are we missing?The role of oxidative stress and antioxidants in diabetic complicationsAtorvastatin alleviates experimental diabetic cardiomyopathy by suppressing apoptosis and oxidative stress.Antioxidant strategies in the management of diabetic neuropathy.Experimental diabetes treated with trigonelline: effect on β cell and pancreatic oxidative parameters.
P2860
Q30301118-4C566C8E-0C85-4865-A5A2-AF16ACC95042Q33572265-1B4F649B-E5E0-41C9-86FC-B8FCE1E10CABQ34517974-AF21E26E-3815-4A64-AC40-218B5C07C5E3Q35165194-9F4B79D3-DD1C-4AAE-A367-1BDFA72F5C3AQ36741562-38F711CC-D28C-431A-A21A-BCFB28AE57A3Q37001203-3D7CC126-0847-4AC8-9CA3-CC74B5D88EDEQ37100174-9F8BE923-0BEC-40F3-A581-D8A37FDFE649Q37742799-35645297-3BE9-433F-B748-398CE7581242Q37900100-D6B3DA04-F5B5-4921-9581-38B873C9DB46Q37989150-3372BDC1-3CAA-4162-9198-0FA890DD18D8Q40871248-08D99FD7-1EDE-4946-A2A2-42B86889681DQ42180667-78A64796-6639-4DCB-A5EB-D414204A5AE6Q45769262-E398137A-996F-473D-863A-D490C7037CB4
P2860
Dietary supplementation with vitamin E ameliorates cardiac failure in type I diabetic cardiomyopathy by suppressing myocardial generation of 8-iso-prostaglandin F2alpha and oxidized glutathione
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dietary supplementation with v ...... alpha and oxidized glutathione
@en
Dietary supplementation with v ...... lpha and oxidized glutathione.
@nl
type
label
Dietary supplementation with v ...... alpha and oxidized glutathione
@en
Dietary supplementation with v ...... lpha and oxidized glutathione.
@nl
prefLabel
Dietary supplementation with v ...... alpha and oxidized glutathione
@en
Dietary supplementation with v ...... lpha and oxidized glutathione.
@nl
P2093
P2860
P1476
Dietary supplementation with v ...... alpha and oxidized glutathione
@en
P2093
Holly M Smith
Michael F Hill
Milton Hamblin
P2860
P304
P356
10.1016/J.CARDFAIL.2007.07.002
P577
2007-12-01T00:00:00Z